BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38677722)

  • 1. Breast Relapse of Pediatric B-Cell Acute Lymphoblastic Leukemia After CAR-T Therapy Detected by
    Perrone E; Taralli S; Pagliara D; Larocca LM; Vinti L; Leccisotti L
    Anticancer Res; 2024 May; 44(5):2243-2245. PubMed ID: 38677722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of peripheral blood MRD and 18F-FDG PET in the post-CAR relapse setting: a case study of discordant peripheral blood and bone marrow MRD.
    Schultz L; Davis KL; Walkush A; Baggott C; Erickson C; Ramakrishna S; Aftandilian C; Lacayo N; Nadel HR; Oak J; Mackall CL
    J Immunother Cancer; 2023 Feb; 11(2):. PubMed ID: 36849202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole-body
    Gajjala SR; Hulikal N; Kadiyala S; Kottu R; Kalawat T
    Indian J Med Res; 2018 Mar; 147(3):256-262. PubMed ID: 29923514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of baseline and early response FDG-PET/CT in patients with refractory and relapsed aggressive B-cell lymphoma undergoing CAR-T cell therapy.
    Georgi TW; Kurch L; Franke GN; Jentzsch M; Schwind S; Perez-Fernandez C; Petermann N; Merz M; Metzeler K; Borte G; Hoffmann S; Herling M; Denecke T; Kluge R; Sabri O; Platzbecker U; Vučinić V
    J Cancer Res Clin Oncol; 2023 Aug; 149(9):6131-6138. PubMed ID: 36662305
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Kroeze E; Padilla LA; Burkhardt B; Attarbaschi A; von Mersi H; Kebudi R; Nievelstein RAJ; Tolboom N; Hagleitner MM; Kuiper RP; Beishuizen A; Loeffen JLC
    Pediatr Blood Cancer; 2023 Nov; 70(11):e30642. PubMed ID: 37638834
    [No Abstract]   [Full Text] [Related]  

  • 7. Characterization of extramedullary disease in B-ALL and response to CAR T-cell therapy.
    Holland EM; Yates B; Ling A; Yuan CM; Wang HW; Stetler-Stevenson M; LaLoggia M; Molina JC; Lichtenstein DA; Lee DW; Ligon JA; Shalabi H; Ahlman MA; Shah NN
    Blood Adv; 2022 Apr; 6(7):2167-2182. PubMed ID: 34920453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MRI and 18F-FDG-PET/CT in a rare case of early (precursor) B-lymphoblastic leukaemia with bone involvement as initial manifestation.
    Cistaro A; La Delfa V; Di Rosa G; Cogoni M; Quartuccio N
    Nucl Med Rev Cent East Eur; 2017; 20(1):57-59. PubMed ID: 28218349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FDG PET/CT Demonstrated Precursor B-cell Lymphoblastic Lymphoma in a Pediatric Patient With Hemophilia B.
    Liu Z; Yang X; Liu J; Yang J
    Clin Nucl Med; 2019 Aug; 44(8):683-685. PubMed ID: 31274624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical utility of F-18 FDG PET/CT in recurrent breast carcinoma.
    Manohar K; Mittal BR; Senthil R; Kashyap R; Bhattacharya A; Singh G
    Nucl Med Commun; 2012 Jun; 33(6):591-6. PubMed ID: 22334135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imaging Biomarkers to Predict Outcomes in Patients With Large B-Cell Lymphoma With a Day 28 Partial Response by
    Lutfi F; Goloubeva O; Kowatli A; Gryaznov A; Kim DW; Dureja R; Margiotta P; Matsumoto LR; Bukhari A; Ahmed N; Mushtaq MU; Law JY; Lee ST; Kocoglu MH; Atanackovic D; Yared JA; Hardy NM; McGuirk JP; Rapoport AP; Chen W; Dahiya S
    Clin Lymphoma Myeloma Leuk; 2023 Oct; 23(10):757-763. PubMed ID: 37453865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of FDG PET/CT in Patients With Lymphoma Treated With Chimeric Antigen Receptor T-Cell Therapy: Current Concepts.
    Murad V; Kohan A; Ortega C; Prica A; Veit-Haibach P; Metser U
    AJR Am J Roentgenol; 2024 Mar; 222(3):e2330301. PubMed ID: 38054958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic efficacy of 18F-FDG-PET or PET/CT in breast cancer with suspected recurrence: a systematic review and meta-analysis.
    Xiao Y; Wang L; Jiang X; She W; He L; Hu G
    Nucl Med Commun; 2016 Nov; 37(11):1180-8. PubMed ID: 27428888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of
    Piccardo A; Trimboli P; Puntoni M; Foppiani L; Treglia G; Naseri M; Bottoni GL; Massollo M; Sola S; Ferrarazzo G; Bruzzone M; Catrambone U; Arlandini A; Paone G; Ceriani L; Cabria M; Giovanella L
    Thyroid; 2019 Apr; 29(4):549-556. PubMed ID: 30864903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrating CAR T-Cell Therapy and Transplantation: Comparisons of Safety and Long-Term Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation After CAR T-Cell or Chemotherapy-Based Complete Remission in B-Cell Acute Lymphoblastic Leukemia.
    Zhao YL; Liu DY; Sun RJ; Zhang JP; Zhou JR; Wei ZJ; Xiong M; Cao XY; Lu Y; Yang JF; Zhang X; Lu DP; Lu P
    Front Immunol; 2021; 12():605766. PubMed ID: 34025637
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Ruff A; Ballard HJ; Pantel AR; Namoglu EC; Hughes ME; Nasta SD; Chong EA; Bagg A; Ruella M; Farwell MD; Svoboda J; Sellmyer MA
    Mol Imaging Biol; 2021 Dec; 23(6):818-826. PubMed ID: 34231105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 18F-FDG PET/CT in the diagnosis of an extranodal relapse of diffuse large B-cell lymphoma (DLBCL): a clinical case with a literature review.
    Chaushev B; Micheva I; Mechmed M; Balev B; Bocheva Y; Ivanova D; Krasnaliev I; Lozanova R; Klisarova A; Bochev P; Dancheva J
    Nucl Med Rev Cent East Eur; 2016; 19(B):11-13. PubMed ID: 27813622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early 18F-FDG PET Flare-up Phenomenon After CAR T-Cell Therapy in Lymphoma.
    Boursier C; Perrin M; Bordonne M; Campidelli A; Verger A
    Clin Nucl Med; 2022 Feb; 47(2):e152-e153. PubMed ID: 34406181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD19 CAR-T Cells With Membrane-Bound IL-15 for B-Cell Acute Lymphoblastic Leukemia After Failure of CD19 and CD22 CAR-T Cells: Case Report.
    Sun Y; Su Y; Wang Y; Liu N; Li Y; Chen J; Qiao Z; Niu J; Hu J; Zhang B; Ning H; Hu L
    Front Immunol; 2021; 12():728962. PubMed ID: 34691036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and Efficacy of Chimeric Antigen Receptor T-Cell Therapy in Children With Central Nervous System Leukemia.
    Zhang L; Zuo Y; Lu A; Wu J; Jia Y; Wang Y; Zhang L
    Clin Lymphoma Myeloma Leuk; 2021 Apr; 21(4):e410-e414. PubMed ID: 33526401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.